Support and Resistance Basics

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

Top 10 Correlated Stocks

NVAX


In the News

10:53 13 Aug 2022 NVAX

Here's Why Novavax Stock Is Trading Higher

Novavax, Inc. (NASDAQ: NVAX) shares are trading higher by 2.80% to $41.47, though off the session high of $43.06 after the company announced its Novaxovid COVID-19 vaccine has been approved in South Korea for use in adolescents aged 12 through 17. What Happened?

07:45 13 Aug 2022 NVAX

Why Novavax Stock Was Plummeting This Week

A hugely disappointing quarter and new bear takes on the company by analysts made for a very bad set of trading days.

05:52 13 Aug 2022 NVAX

Novavax's Revenue Could Fall Even More -- and It's Actually Good News

Believe it or not, Novavax's revenue could decline and still cause the stock to soar.

08:30 13 Aug 2022 NVAX

Is This Battered Growth Stock Still a Buy After Its Latest Stumble?

Its flagship vaccine product isn't selling as much as it used to.

02:23 13 Aug 2022 NVAX

3 Companies Growing Revenue Fast

S&P 500 stocks have posted average growth of 6.54% in annual total revenue from 2017 to 2021. The benchmark index for the U.S. stock market closed at 4,122.47 on Tuesday, up nearly 70% over the past five years through Aug. 9.

01:32 13 Aug 2022 NVAX

Novavax (NVAX) Q2 Earnings Miss, Cuts '22 Sales Guidance by Half

Novavax (NVAX) reports dismal results in second-quarter 2022. The stock dives in after-market trading after management slashes revenue guidance for 2022 by half.

11:45 13 Aug 2022 NVAX

Novavax tumbles 31% as waning COVID-19 vaccine demand hits revenue forecast

Novavax fell 31% Tuesday amid falling demand for the COVID-19 shot from low and middle-income nations, which caused the company to cut its annual expectations in half.

11:30 13 Aug 2022 NVAX

Novavax CEO on COVID-19 boosters: ‘I dont think we're too late'

Novavax CEO Stanley Erck speaks with Yahoo Finance's Anjalee Khemlani about the company's cut forecast for vaccine sales, its outlook for COVID booster development, and growth.

11:20 13 Aug 2022 NVAX

Novavax cuts 2022 revenue guidance in half, plus Good RX soars resolves issue with grocery chain

Yahoo Finance's Anjalee Khemlani breaks down quarterly earnings for Novavax and GoodRx as well as how the market is reacting.

11:00 13 Aug 2022 NVAX

Stock Market Today: Dow Jones, S&P 500 Drop Ahead Of Key Inflation Data; Novavax Stock Falls After Cutting Revenue Guidance

Stock market indices fell Tuesday morning ahead of key inflation data.

Financial details

Company Rating
Strong Buy
Market Cap
4.71B
Income
-1.32B
Revenue
1.3B
Book val./share
0.85
Cash/share
20.55
Dividend
-
Dividend %
-
Employees
1.54K
Optionable
No
Shortable
Yes
Earnings
02 Nov 2022
P/E
-2.2
Forward P/E
9.53
PEG
-0.16
P/S
2.72
P/B
-7.77
P/C
2.02
P/FCF
-3.98
Quick Ratio
0.73
Current Ratio
0.99
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-17.58
EPS next Y
4.35
EPS next Q
-4.15
EPS this Y
222.42%
EPS next Y
-124.74%
EPS next 5Y
-124.74%
EPS last 5Y
13.22%
Revenue last 5Y
105.63%
Revenue Q/Q
172.13%
EPS Q/Q
-123.79%
-
-
-
-
SMA20
-20.13%
SMA50
-0.72%
SMA100
-33.88%
Inst Own
44.09%
Inst Trans
-0.73%
ROA
-56%
ROE
2440%
ROC
-3.01%
Gross Margin
42%
Oper. Margin
-118%
Profit Margin
-124%
Payout
-
Shs Outstand
78.13M
Shs Float
77.91M
-
-
-
-
Target Price
168
52W Range
34.88-277.8
52W High
-85.03%
52W Low
+21.97%
RSI
36.28
Rel Volume
0.69
Avg Volume
7.22M
Volume
4.99M
Perf Week
-32.14%
Perf Month
-19.37%
Perf Quarter
-49.36%
Perf Half Y
-54.82%
-
-
-
-
Beta
1.5794
-
-
Volatility
9.47%, 8.83%
Prev Close
2.8%
Price
41.47
Change
-0.34%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
2.131.850.778.2615.41
Net income per share
-12.56-9.99-5.51-7.27-23.44
Operating cash flow per share
-9.48-10-5.67-0.744.34
Free cash flow per share
-9.76-10.07-5.75-1.693.57
Cash per share
10.754.983.2712.3520.36
Book value per share
-6.95-9.08-7.7210.9-4.73
Tangible book value per share
-11.15-12.25-10.078.45-6.56
Share holders equity per share
-6.95-9.08-7.7210.9-4.73
Interest debt per share
22.6817.9213.8111.456.39
Market cap
599.97M843.05M168.7M12.72B6.17B
Enterprise value
811.43M1.09B410.49M12.81B5.11B
P/E ratio
-3.26-4.56-1.27-30.4-3.54
Price to sales ratio
19.2424.599.0426.745.38
POCF ratio
-4.33-4.56-1.23-298.9119.1
PFCF ratio
-4.2-4.53-1.22-130.8723.24
P/B Ratio
-5.9-5.02-0.9120.27-17.54
PTB ratio
-5.9-5.02-0.9120.27-17.54
EV to sales
26.0331.852226.934.46
Enterprise value over EBITDA
-5.08-6.64-3.57-32.16-3.04
EV to operating cash flow
-5.85-5.91-3-301.0415.82
EV to free cash flow
-5.68-5.87-2.96-131.8119.24
Earnings yield
-0.31-0.22-0.79-0.03-0.28
Free cash flow yield
-0.24-0.22-0.82-0.010.04
Debt to equity
-3.12-1.9-1.720.51-0.92
Debt to assets
1.341.812.080.61.14
Net debt to EBITDA
-1.32-1.51-2.11-0.230.63
Current ratio
2.762.623.772.150.9
Interest coverage
-12.2-14.27-9.89-27.52-79.83
Income quality
0.7511.030.1-0.19
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
1.1111.840.310.26
Research and developement to revenue
5.45.076.11.572.21
Intangibles to total assets
0.20.280.330.090.05
Capex to operating cash flow
0.030.010.011.28-0.18
Capex to revenue
-0.13-0.04-0.1-0.11-0.05
Capex to depreciation
-0.43-0.17-0.33-11.18-4.54
Stock based compensation to revenue
0.640.530.910.270.16
Graham number
44.3245.1930.9242.2149.93
ROIC
-0.75-1.07-0.82-0.42-9.05
Return on tangible assets
-0.76-1.24-1.14-0.29-0.71
Graham Net
-16.43-15.03-11.39-0.83-14.41
Working capital
129.64M73.74M71.45M668.53M-235.2M
Tangible asset value
-163.17M-226.44M-242.75M486.11M-487.92M
Net current asset value
-200.91M-256.64M-261.73M292.93M-773.31M
Invested capital
-3.12-1.9-1.721.03-1.29
Average receivables
00134.76M262.01M358.5M
Average payables
29.97M31.82M28.62M54.33M90.69M
Average inventory
00000
Days sales outstanding
00146.69201.08144.88
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
002.491.822.52
Payables turnover
00000
Inventory turnover
00000
ROE
1.811.10.71-0.674.96
Capex per share
-0.29-0.07-0.08-0.95-0.77

Quarterly Fundamentals Overview

Last date of statement is 2022-03-31 for Q1

Metric History 2021-03-312021-06-302021-09-302021-12-31 2022-03-31
Revenue per share
6.124.022.392.947.91
Net income per share
-3.05-4.75-4.31-11.182.66
Operating cash flow per share
9.081.95-1.9-4.53-1.16
Free cash flow per share
8.891.74-2.06-4.74-1.38
Cash per share
27.3527.9925.9120.0220.55
Book value per share
14.2310.066.17-4.650.85
Tangible book value per share
12.368.184.34-6.45-0.92
Share holders equity per share
14.2310.066.17-4.650.85
Interest debt per share
6.375.895.786.075.82
Market cap
13.24B15.74B15.5B10.83B5.63B
Enterprise value
11.71B14.09B13.99B9.76B4.5B
P/E ratio
-14.86-11.17-12.01-3.26.92
Price to sales ratio
29.6152.886.6448.729.31
POCF ratio
19.97108.97-109.01-31.62-63.62
PFCF ratio
20.39121.74-100.4-30.18-53.46
P/B Ratio
12.7421.1133.59-30.7886.2
PTB ratio
12.7421.1133.59-30.7886.2
EV to sales
26.1847.2878.243.957.44
Enterprise value over EBITDA
-55.08-41.4-45.56-11.920.71
EV to operating cash flow
17.6597.58-98.39-28.52-50.85
EV to free cash flow
18.03109.02-90.62-27.22-42.73
Earnings yield
-0.02-0.02-0.02-0.080.04
Free cash flow yield
0.050.01-0.01-0.03-0.02
Debt to equity
0.330.450.7-0.920
Debt to assets
0.60.730.821.140.98
Net debt to EBITDA
7.224.834.921.29-5.2
Current ratio
1.861.431.240.91.04
Interest coverage
-43.11-57.95-59.27-160.5646.3
Income quality
-2.98-0.410.440.4-0.44
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.140.250.430.380
Research and developement to revenue
1.331.912.284.330.63
Intangibles to total assets
0.050.050.050.050.05
Capex to operating cash flow
-0.02-0.10.090.050.19
Capex to revenue
-0.03-0.05-0.07-0.07-0.03
Capex to depreciation
-5.95-6.29-2.86-4.46-2.49
Stock based compensation to revenue
0.120.180.250.140.05
Graham number
31.2432.824.4834.27.15
ROIC
-0.15-0.31-0.38-4.430.36
Return on tangible assets
-0.09-0.13-0.13-0.350.08
Graham Net
6.921.68-1.14-14.17-10.29
Working capital
1.04B703.48M420.77M-235.2M86.4M
Tangible asset value
902.98M605.99M324.32M-487.92M-69.97M
Net current asset value
677.55M350.97M69.58M-773.31M-422.15M
Invested capital
0.440.580.93-1.296.74
Average receivables
278.59M263.18M282.48M454.99M466.57M
Average payables
120.33M100.52M93.31M127.05M131.09M
Average inventory
00000
Days sales outstanding
20.5721.5555.34184.2971.17
Days payables outstanding
0000799.89
Days of inventory on hand
0000631.3
Receivables turnover
4.384.181.630.491.26
Payables turnover
00000.11
Inventory turnover
00000.14
ROE
-0.21-0.47-0.72.413.11
Capex per share
-0.19-0.2-0.16-0.22-0.22

Something similar

Top Correlated Stocks
Similar Market Cap